SIOPEN
Pronunciation: SIE-oh-pen
Also written as: SIOPEN — European Society for Paediatric Oncology European Neuroblastoma
European cooperative group conducting neuroblastoma clinical trials and research protocols.
Full Definition
The European Society for Paediatric Oncology European Neuroblastoma (SIOPEN) is a collaborative research network that develops and conducts multinational clinical trials for pediatric neuroblastoma patients across Europe. SIOPEN protocols are widely adopted internationally and represent current standard-of-care approaches for risk-stratified neuroblastoma treatment. The organization publishes treatment guidelines, coordinates research initiatives, and maintains patient registries that inform evidence-based care decisions. SIOPEN protocols often serve as reference standards for institutional treatment plans.
Usage
Usage note: Distinguish from SIOP (general pediatric oncology organization) and COG (North American cooperative group).
In Context
- "The patient was enrolled on the SIOPEN high-risk neuroblastoma protocol with immunotherapy maintenance." — Clinical trial documentation
- "Treatment modifications followed SIOPEN guidelines for grade 4 hematologic toxicity." — Protocol amendment